Qilu Pharma Spain is the European subsidiary of Qilu Pharmaceutical, one of the leading pharmaceutical companies in China and focuses on the research and development, manufacturing and marketing of generics and biosimilars, both of active pharmaceutical ingredients and finished dosage forms in several therapeutical areas.
We have eight manufacturing and research sites over a total surface area of 2.8 km², in which 8,000 employees work (a large percentage of them are highly qualified) and we have over 200 products between active pharmaceutical ingredients and finished dosage forms with presence in 50 countries throughout Europe, United States, Australia, Latin America, Middle East, Africa and Asia.
Our mission is to develop and provide high quality medicines to improve the quality of life of patients, providing medical professionals with drugs produced using the most advanced technologies and applying the most rigorous quality standards.
We are committed to people who have certain oncological, infectious, cardiovascular, central nervous system, respiratory and ophthalmological illnesses, among others.
Qilu´s brand value has been built on the basis of high quality products and high-level service.